S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

SOPHiA GENETICS Prices $50 Million Public Offering

SOPHiA GENETICS is raising $50 million through a public offering of 10,526,000 ordinary shares, priced at $4.75 each. The Nasdaq-listed healthcare technology firm, known for its AI-driven precision medicine platform, expects to close the transaction on June 18, 2026, pending standard closing requirements.

SOPHiA GENETICS Prices $50 Million Public Offering
Photo: Bio & News

The company has granted underwriters a 30-day option to purchase an additional 1,578,900 shares to cover potential over-allotments. TD Cowen is leading the book-running process, supported by Guggenheim Securities, while BTIG and Craig-Hallum serve as lead managers for the offering.

Proceeds from the sale will be collected before accounting for underwriting discounts, commissions, and other associated expenses. The offering is being conducted under a registration statement previously filed with the U.S. Securities and Exchange Commission. The company clarified that the shares are not being offered or marketed in Switzerland, as the transaction does not comply with the Swiss Financial Services Act.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!